A CASE OF POLY-INFECTION WITH cUTI AND GRADE III BED SORE IN TYPE II DIABETES TREATED WITH NEW ANTIBIOTIC ADJUVANT ENTITY: A CASE REPORT


Suneet Kumar Verma

Abstract


Critically ill patients with diabetes are commonly associated with urinary tract infection and high-risk of bed sores or pressure ulcers. We report a case
of 72 years male patient, a known case of meningoencephalitis, treated 1 month back. He arrived to our emergency department, with chief complaints
of fever and increased drowsiness since 10-12 days. Based on the initial examination, the patient was empirically managed with intravenous
meropenem 1 g every 8 hrs. However, due to patient poor clinical response antibiotic therapy was switched to Elores 1.5 g B.D dose with 90 minutes
infusion. The patient received Elores therapy for 7 days, based on lab reports and general condition, he was put on oral antibiotics and shifted to ward.
On the 5
day of post ward transfer, the patient developed mild pleural effusion with mild hypokinesis, he was again shifted to Medical Intensive Care
Unit. Cardiology consultation was sought and was managed. In view of suspected hospital-acquired pneumonia, prophylactic treatment of Elores 1.5 g
B.D was continued for 5 days. The patient responded to the treatment well, was stable and discharged with follow-up advice.
th
Keywords: Antibiotic adjuvant entity, Complicated urinary tract infections, Elores, Poly-infection.


| PDF |

References


Longdoh NA. Uropathogens from diabetic patients with asymptomatic

bacteriuria and urinary tract infections. West London Med J

;5(1):7-14.

Janifer J, Geethalakshmi S, Satyavani K, Viswanathan V. Prevalence of

lower urinary tract infection in South Indian type 2 diabetic subjects.

Indian J Nephrol 2009;19(3):107-11.

Tayyib N, Coyer F, Lewis P. Pressure ulcers in the adult intensive care

unit: A literature review of patient risk factors and risk assessment

scales. J Nurs Educ Pract 2013;3(11):28-42.

Frank C, Bayoumi I, Westendorp C. Approach to infected skin ulcers.

Can Fam Physician 2005;51(10):1352-9.

Asian J Pharm Clin Res, Vol 9, Issue 1, 2016, 7-9

Verma

Kirketerp-Moller K, Zulkowski K, James G. Chronic wound

colonization, infection, and biofilms. Biofilm Infect 2011;11-24 .

Chaudhary M, Payasi A. A randomized, open-label, prospective,

multicenter phase-III clinical trial of Elores in lower respiratory tract

and urinary tract infections. J Pharm Res 2013;6(4):409-14.

Chaudhary M, Payasi A. Antimicrobial susceptibility patterns and

molecular characterization of Klebsiella pneumoniae clinical isolates

from north Indian patients. Int J Med Med Sci 2013;46:1218-24.

Chaudhary M, Payasi A. Role of EDTA and CSE1034 in curli formation

and biofilm eradication of Klebsiella pneumoniae: A comparison with

other drugs. J Antibiot (Tokyo) 2012;65(12):631-3.

Sahu M, Sanjith S, Bhalekar P, Keny D. Waging war against extended

spectrum Beta lactamase and metallobetalactamase producing

pathogens- novel adjuvant antimicrobial agent cse1034- an extended

hope. J Clin Diagn Res 2014;8(6):DC20-3.

Chaudhary M, Payasi A. Clinical, microbial efficacy and tolerability

of Elores, a novel antibiotic adjuvant entity in ESBL producing

pathogens: Prospective randomized controlled clinical trial. J Pharm

Res 2013;7:275-80.




About this article

Title

A CASE OF POLY-INFECTION WITH cUTI AND GRADE III BED SORE IN TYPE II DIABETES TREATED WITH NEW ANTIBIOTIC ADJUVANT ENTITY: A CASE REPORT

Date

01-01-2016

Additional Links

Manuscript Submission

Journal

Asian Journal of Pharmaceutical and Clinical Research
Vol 9 Issue 1 (January-February) 2016 Page: 7-9

Print ISSN

0974-2441

Online ISSN

2455-3891

Authors & Affiliations

Suneet Kumar Verma
Alchemist Hospital Panchkula,
India


Article Tools


Email this article (Login required)
Email the author (Login required)

Refbacks

  • There are currently no refbacks.